bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 22, 2023
Abstract
Continued
high-level
spread
of
SARS-CoV-2
has
enabled
an
accumulation
changes
within
the
Spike
glycoprotein,
leading
to
resistance
neutralising
antibodies
and
concomitant
entry
requirements
that
increased
viral
transmission
fitness.
Herein,
we
demonstrate
a
significant
change
in
angiotensin-converting
enzyme
2
(ACE2)
transmembrane
serine
protease
(TMPRSS2)
dependent
by
primary
isolates
occurred
upon
arrival
Omicron
lineages.
Mechanistically
show
this
shift
be
function
two
distinct
ACE2
pools
based
on
TMPRS22
association
with
Collectrin-Like
Domain
(CLD).
In
engineered
cells
overexpressing
TMPRSS2,
ACE2/TMPRSS2
complexes
led
either
augmentation
or
attenuation
infectivity
pre-Omicron
lineages,
respectively.
Mutagenesis
ACE2-CLD
TMPRSS2
cleavage
site
restored
across
all
lineages
through
enabling
binding
facilitated
activation
fusion.
Our
data
supports
evolution
towards
use
unable
form
consistent
structure
as
chaperone
for
many
tissue
specific
amino
acid
transport
proteins.
Graphical
Abstract:
ACE2-TMPRSS2
pool
model
tropism.
A.
&-B.
reconcile
evolving
tropism
vivo
.
Both
SARS-CoV-1
early
(pre-Omicron)
have
molecular
dual
tropism,
efficient
when
(blue
protein)
can
(green
settings
where
is
excluded
from
(C4-ACE2
CLD).
both
initially
engages
spike
fusion
then
triggered
S2
domain
B.
Over
time,
(with
without
TMPRSS2)
been
lost,
consolidation
no
longer
complex.
With
could
enable
fusogenic
(TMPRSS2
“off”
confirmation”).
Rather,
only
uncoupled
facilitate
latter
S2.
C.
time
further
consolidated
over
generations
omicron
2022
(BA.1,
BA.2
BA.5)
2023
(XBB.1.5)
now
2024
JN.1
such
KP.3.
Overall,
initial
clades
similar
observed
SARS-CoV-1,
replication
proceeding
tissues
would
prevalent
(e.g.
Lung).
The
away
structurally
solute
carriers
SLCA619
SLCA620)
selection
manner
sustained
fitness
human
population.
BMJ Global Health,
Journal Year:
2023,
Volume and Issue:
8(7), P. e012328 - e012328
Published: July 1, 2023
Objectives
To
compare
severity
and
clinical
outcomes
from
Omicron
as
compared
with
the
Delta
variant
to
between
sublineages.
Methods
We
searched
WHO
COVID-19
Research
database
for
studies
that
patients
variant,
separately
sublineages
BA.1
BA.2.
A
random-effects
meta-analysis
was
used
pool
estimates
of
relative
risk
(RR)
variants
Heterogeneity
assessed
using
I
2
index.
Risk
bias
tool
developed
by
Clinical
Advances
through
Information
Translation
team.
Results
Our
search
identified
1494
42
met
inclusion
criteria.
Eleven
were
published
preprints.
Of
studies,
29
adjusted
vaccination
status;
12
had
no
adjustment;
1,
adjustment
unclear.
Three
included
versus
As
Delta,
individuals
infected
61%
lower
death
(RR
0.39,
95%
CI
0.33
0.46)
56%
hospitalisation
0.44,
0.34
0.56).
similarly
associated
intensive
care
unit
(ICU)
admission,
oxygen
therapy,
non-invasive
invasive
ventilation.
The
pooled
ratio
outcome
when
comparing
BA.2
0.55
(95%
0.23
1.30).
Discussion
hospitalisation,
ICU
ventilation
Delta.
There
difference
in
PROSPERO
registration
number
CRD42022310880.
BMC Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: June 26, 2023
The
serial
interval
is
the
period
of
time
between
symptom
onset
in
primary
case
and
secondary
case.
Understanding
important
for
determining
transmission
dynamics
infectious
diseases
like
COVID-19,
including
reproduction
number
attack
rates,
which
could
influence
control
measures.
Early
meta-analyses
COVID-19
reported
intervals
5.2
days
(95%
CI:
4.9-5.5)
original
wild-type
variant
4.87-5.47)
Alpha
variant.
has
been
shown
to
decrease
over
course
an
epidemic
other
respiratory
diseases,
may
be
due
accumulating
viral
mutations
implementation
more
effective
nonpharmaceutical
interventions.
We
therefore
aggregated
literature
estimate
Delta
Omicron
variants.
Current Opinion in Virology,
Journal Year:
2023,
Volume and Issue:
62, P. 101349 - 101349
Published: Aug. 28, 2023
SARS
coronavirus
2
(SARS-CoV-2),
the
causative
agent
of
COVID-19,
emerged
in
China
December
2019.
Vaccines
developed
were
very
effective
initially,
however,
virus
has
shown
remarkable
evolution
with
multiple
variants
spreading
globally
over
last
three
years.
Nowadays,
newly
emerging
Omicron
lineages
are
gaining
substitutions
at
a
fast
rate,
resulting
escape
from
neutralization
by
antibodies
that
target
Spike
protein.
Tools
to
map
impact
on
further
antigenic
SARS-CoV-2,
such
as
cartography,
may
be
helpful
update
SARS-CoV-2
vaccines.
In
this
review,
we
focus
highlighting
protein
individually
and
combination
immune
escape.
Clinical Infectious Diseases,
Journal Year:
2022,
Volume and Issue:
76(5), P. 786 - 794
Published: Oct. 26, 2022
Abstract
Background
Aerosol
inhalation
is
recognized
as
the
dominant
mode
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
transmission.
Three
highly
transmissible
lineages
evolved
during
pandemic.
One
hypothesis
to
explain
increased
transmissibility
that
natural
selection
favors
variants
with
higher
rates
viral
aerosol
shedding.
However,
extent
shedding
successive
SARS-CoV-2
unknown.
We
aimed
measure
infectivity
and
rate
into
exhaled
breath
(EBA)
by
individuals
Delta
Omicron
waves
compared
those
prior
from
our
previously
published
work.
Methods
Individuals
disease
2019
(COVID-19)
(n
=
93;
32
vaccinated
20
boosted)
were
recruited
give
samples,
including
30-minute
samples
a
Gesundheit-II
EBA
sampler.
Samples
quantified
for
RNA
using
reverse-transcription
polymerase
chain
reaction
cultured
virus.
Results
Alpha
4),
3),
29)
cases
shed
significantly
more
copies
EBAs
than
infected
ancestral
strains
not
associated
57).
All
fully
most
boosted.
virus
1
boosted
3
cases.
Conclusions
Alpha,
Delta,
independently
high
phenotypes,
demonstrating
convergent
evolution.
Vaccinated
can
infectious
via
EBA.
These
findings
support
role
aerosols
in
transmission
SARS-CoV-2.
Monitoring
new
emerging
pathogens
be
an
important
component
future
threat
assessments
guide
interventions
prevent
The Journal of Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
228(9), P. 1231 - 1239
Published: June 24, 2023
Understanding
severity
of
infections
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
and
its
variants
is
crucial
to
inform
public
health
measures.
Here
we
used
disease
2019
(COVID-19)
patient
data
from
Hong
Kong
characterize
the
profile
COVID-19.Time-varying
age-specific
effective
measured
by
case
hospitalization
risk
fatality
was
estimated
all
individual
COVID-19
collected
in
23
January
2020
through
26
October
2022
over
6
epidemic
waves.
The
intrinsic
Omicron
BA.2
compared
estimate
for
ancestral
strain
unvaccinated
patients
without
previous
infections.With
32
222
hospitalizations
9669
deaths
confirmed
waves,
time-varying
dramatically
increased
<10%
before
largest
fifth
wave
41%
during
peak
when
hospital
resources
were
severely
constrained.
hospitalized
cases
comparable
estimates
strain.
During
epidemics
predominated
BA.2,
highest
among
older
patients.Omicron
has
Wuhan
strain,
although
substantially
lower
due
vaccination.
Antiviral Research,
Journal Year:
2024,
Volume and Issue:
225, P. 105869 - 105869
Published: March 26, 2024
SARS-CoV-2
Omicron
subvariants
with
increased
transmissibility
and
immune
evasion
are
spreading
globally
alarming
persistence.
Whether
the
mutations
evolution
of
spike
(S)
alter
viral
hijacking
human
TMPRSS2
for
entry
remains
to
be
elucidated.
This
is
particularly
important
investigate
because
large
number
diversity
S
reported
since
emergence
BA.1.
Here
we
report
that
a
molecular
determinant
all
clinical
isolates
tested
in
lung
cells,
including
ancestral
(BA.1,
BA.2,
BA.5),
contemporary
(BQ.1.1,
XBB.1.5,
EG.5.1)
currently
circulating
BA.2.86.
First,
used
co-transfection
assay
demonstrate
endoproteolytic
cleavage
by
subvariants.
Second,
found
N-0385,
highly
potent
inhibitor,
robust
inhibitor
virus-like
particles
harbouring
protein
Third,
show
N-0385
exhibits
nanomolar
broad-spectrum
antiviral
activity
against
live
Calu-3
cells
primary
patient-derived
bronchial
epithelial
cells.
Interestingly,
10-20
times
more
than
repositioned
camostat,
BA.5,
EG.5.1,
We
further
shows
broad
synergistic
clinically
approved
direct-acting
antivirals
(DAAs),
i.e.,
remdesivir
nirmatrelvir,
subvariants,
demonstrating
potential
therapeutic
benefits
multi-targeted
treatment
based
on
DAAs.
International Journal of Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
131, P. 19 - 25
Published: March 21, 2023
As
the
world
transitions
to
COVID-19
endemicity,
studies
focusing
on
aerosol
shedding
of
highly
transmissible
SARS-CoV-2
variants
concern
(VOCs)
are
vital
for
calibration
infection
control
measures
against
VOCs
that
likely
circulate
seasonally.
This
follow-up
Gesundheit-II
sampling
study
aims
compare
patterns
Omicron
VOC
samples
with
pre-Omicron
analyzed
in
our
previous
study.Coarse
and
fine
from
47
patients
infected
were
collected
during
various
respiratory
activities
(passive
breathing,
talking,
singing)
using
reverse
transcription-quantitative
polymerase
chain
reaction
virus
culture.Compared
variants,
comparable
RNA
copy
numbers
detectable
despite
being
fully
vaccinated.
Patients
also
showed
a
slight
increase
viral
breathing
more
have
persistent
beyond
7
days
after
disease
onset.This
reaffirms
properties
should
guide
continued
layering
public
health
interventions
even
vaccinated
populations.